{"id":"W4388379556","doi":"10.1016/j.ejca.2023.113420","title":"Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Positive Living Society of British Columbia","funders":"Pfizer","keywords":"Palbociclib; Medicine; Placebo; Quality of life (healthcare); Breast cancer; Internal medicine; Oncology; Mood; Cancer; Physical therapy; Gynecology; Metastatic breast cancer; Clinical psychology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001904746,0.000615261,0.001626161,0.0002780384,0.0001999698,0.001004656,0.0004940536,0.0006578888,0.001779147],"category_scores_gemma":[0.002160689,0.0002467743,0.002229281,0.0005290865,0.0003602617,0.0008288623,0.0005311098,0.001551781,0.0001991693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006505811,"about_ca_system_score_gemma":0.0005587722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008035176,"about_ca_topic_score_gemma":0.00148729,"domain_scores_codex":[0.9987103,0.0007238621,0.0000860863,0.0002039946,0.0001326962,0.0001430813],"domain_scores_gemma":[0.9989061,0.0003374103,0.0003803644,0.00007898485,0.00005920473,0.0002379894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7931759,0.003014527,0.1354784,0.001382977,0.01971616,0.0001917759,0.0001085343,0.002357428,0.001873787,0.0003328467,0.002528331,0.03983934],"study_design_scores_gemma":[0.2736033,0.08475805,0.6051201,0.000376542,0.02401868,0.0005862194,0.0002681788,0.003136562,0.001511726,0.000873634,0.005605347,0.0001416562],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903876,0.006415673,0.0001587457,0.0002361404,0.0001037628,0.0001418172,0.001640642,0.00001061224,0.000904952],"genre_scores_gemma":[0.9958222,0.001342494,0.0001331316,0.0002364102,0.0000915571,0.000142099,0.001862737,0.000004003339,0.0003654033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001904746,"threshold_uncertainty_score":0.01007336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01585629647036171,"score_gpt":0.2924184670737479,"score_spread":0.2765621706033862,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}